ASPEN PHAR.UN.ADR /1 O.N. (LDZU) — Net Asset Momentum
ASPEN PHAR.UN.ADR /1 O.N. (LDZU) recorded a net asset momentum of 0.0% as of June 2025, with net assets of €84.89 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is ASPEN PHAR.UN.ADR /1 O.N.'s book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
ASPEN PHAR.UN.ADR /1 O.N. Net Asset Momentum (2022–2025)
This chart tracks ASPEN PHAR.UN.ADR /1 O.N.'s year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is +0.0%, with net assets of €84.89 Billion EUR as of June 2025. For live market cap and overall valuation, see LDZU market cap.
Annual Net Asset History for ASPEN PHAR.UN.ADR /1 O.N. (2022–2025)
The table below shows the complete annual net asset history for ASPEN PHAR.UN.ADR /1 O.N. from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check LDZU tangible net worth ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €84.89 Billion | €135.89 Billion | €51.00 Billion | ▲ +0.0% |
| 2024 | €84.86 Billion | €139.06 Billion | €54.20 Billion | ▼ -1.6% |
| 2023 | €86.24 Billion | €134.28 Billion | €48.05 Billion | ▲ +21.6% |
| 2022 | €70.94 Billion | €111.38 Billion | €40.43 Billion | — |